Welcome to Huarong Pharm! Email :
sales@huarongpharm.com
choose yr language here
English
한국어
Deutsch
Le français
日本語
Español
lingua italiana
Structure Search
Batch search
Toggle navigation
Home
(current)
Product Category
Building Blocks
Antibody & Drug Conjugates (ADCs)
API & Intermediates
Natural Products
Reference Compounds & Impurities
Others
Services
Customized Synthesis
Process R&D
APIs and intermediates Production
Quality Research & Registration Application
About us
Our profile
Our culture
Our history
Contact us
Help
How to order
Payment & Shipping
Returns & Refunds
How to get a monthly update
Privacy-Policy
Home
NEWS
NEWS
Huarong People attended CPHI China at Shanghai--2024
Huarong People attended CPHI China at Shanghai--2023
Mirati Therapeutics Announces U.S. FDA Accelerated Approval of KRAZATI™ (adagrasib)
Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment
Novartis to sell its Roche stake in a bilateral transaction to Roche
Risk of presence of mutagenic azido impurities in sartan active substances with a tetrazole ring
Thermo Fisher Acquires PPD for $17.4B
Top 10 Pharmaceutical companies in the world in 2020
Huarong People attended CPHI China at Shanghai--2019
Our Exhibition Schedule for the whole year--2019
Page 1
/ Total 2
First
Prev
Next
Last
20
50
100
200
Goto
Contact Email
Email
sales@huarongpharm.com
Back to top
Support CAS number Batch Search: one CAS number per line
